fbpx Skip to main content
 

Search

Commitment to Immunodermatology Newsroom

Johnson & Johnson’s Commitment to Immunodermatology
Johnson & Johnson’s Commitment to Immunodermatology

Welcome to the Johnson & Johnson Immunodermatology Newsroom! Below, please find the latest data, content, meeting news and leadership messages about our progress and commitment to developing transformational approaches and innovative medicines for diseases like psoriasis (PsO), atopic dermatitis (AD), hidradenitis suppurativa (HS) and bullous pemphigoid (BP).

To read more about Johnson & Johnson Innovative Medicine’s progress and accomplishments in other disease areas, please explore our Gastroenterology, Maternal-Fetal, and Rheumatology Newsrooms. Our Rheumatology Newsroom includes our work in psoriatic arthritis (PsA), an immune-mediated rheumatologic disease that develops in up to 30 percent of people with PsO.1

Dear All,

At Johnson & Johnson Innovative Medicine, we are steadfast in our commitment to address unmet need, uncover novel treatment approaches, and work collaboratively to deliver transformational therapies for patients living with chronic immune-mediated diseases. We understand that significant unmet need remains in many of these diseases, and that patients around the world are struggling to find safe, effective treatments, and maintain symptom-free remission.

Building upon our portfolio of transformational advanced therapies which will continue to offer important treatment options for patients with immune-mediated diseases, we believe the pursuit of novel oral therapies is critical to reaching the many people still not receiving advanced therapies and ensuring patients have more options that offer the potential for remission. Driven by a relentless commitment to patients, we continue to pioneer research to achieve our vision of restoring health for all patients with immune-mediated diseases.

Laura Leonetti
Vice President
Global Therapeutic Area Leader for Dermatology & Rheumatology

 

OUR WORK

 

OUR PEOPLE

 

IN THE NEWS

 

About Psoriasis

Psoriasis (PsO) is an immune-mediated disease resulting in an overproduction of skin cells, which causes raised, red, scaly plaques that may be itchy or painful.2 It is estimated that eight million Americans and more than 125 million people worldwide live with the disease.3 Nearly one-quarter of all people with PsO have cases that are considered moderate to severe.3 Living with PsO can be a challenge and impact life beyond a person’s physical health, including emotional health, relationships, and handling the stressors of life.3 PsO is associated with multiple comorbidities, including psoriatic arthritis, metabolic syndrome, cardiovascular diseases, psychological disorders, inflammatory bowel disease, and additional immune-mediated diseases.4

About Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic disease characterized by swollen, painful lesions, occurring in the armpit (axillae), groin, anal, and breast regions of men and women.5 This progressive disease occurs due to obstruction of hair follicles and secondary infection and sometimes inflammation of certain sweat glands (apocrine glands).5,6 Healing of affected areas is typically associated with progressive scarring (fibrosis).5,6 Formation of chronic epithelialized, sometimes interconnected, sinus tracts occur in severe disease.5 This often leads to the entrapment of perspiration and bacteria in the surrounding tissue, which causes the inflammation and infection.5,6 HS can be extremely painful and debilitating but is rarely life threatening; only occurring when the bacteria infection leads to an overwhelming systemic infection in an individual with a weakened immune system.6,7,8 Although the exact cause of HS is unknown, the condition likely results from a combination of genetic and environmental factors.5

About Atopic Dermatitis

Atopic dermatitis (AD), sometimes referred to as eczema, is a chronic skin disorder affecting more than 9.6 million children and 16.5 million adults in the United States.9 AD is characterized by an overactive immune system that causes damage to the skin barrier, leaving it dry, itchy, and prone to rashes.9 AD may come and go throughout life and is considered a severe condition.9 The condition can cause poor quality of life by interrupting sleep due to itching and/or painful skin, and by impacting the ability to interact with family and friends.9

 

References:
1Psoriatic Arthritis: Causes, Symptoms and Treatment. National Psoriasis Foundation. Available at: https://www.psoriasis.org/about-psoriatic-arthritis/. Accessed June 2023.
2National Psoriasis Foundation. About Psoriasis. Available at: https://www.psoriasis.org/about-psoriasis. Accessed June 2023.
3National Psoriasis Foundation. Statistics. Available at: https://www.psoriasis.org/psoriasis-statistics/. Accessed June 2023.
4Fátima de, M., et al. Psoriasis: classical and emerging comorbidities. An Bras Dermatol. 2015 Jan-Feb;90(1):9-20. Available at: https://pubmed.ncbi.nlm.nih.gov/25672294/#:~:text=Psoriasis%3A%20classical%20and%20emerging%20comorbidities%20Psoriasis%20is%20a,to%20the%20chronic%20inflammatory%20status%20of%20psorias%20%E2%80%A6. Accessed June 2023.
5National Center for Advancing Translational Sciences. Hidradenitis Suppurativa. Available at: https://rarediseases.info.nih.gov/diseases/6658/hidradenitis-suppurativa. Accessed June 2023.
6Johns Hopkins Medicine. Inflamed/Infected Sweat Glands (Hidradenitis). Available at: https://www.hopkinsmedicine.org/health/conditions-and-diseases/hidradenitis-suppurativa#:~:text=Hidradenitis%20occurs%20when%20the%20hair%20follicles%20and%20nearby,and%20under%20the%20breasts%20become%20infected%20and%20inflamed. Accessed June 2023.
7Patient. Hidradenitis Suppurativa. Available at: https://patient.info/skin-conditions/hidradenitis-suppurativa-leaflet#:~:text=In%20severe%20cases%2C%20the%20pus%20tunnels%20down%20under,sometimes%20infection%29%20travels%20deeper%20and%20becomes%20more%20widespread. Accessed June 2023.
8American Academy of Dermatology Association. Hidradenitis Suppurativa: Overview. Available at: https://www.aad.org/public/diseases/a-z/hidradenitis-suppurativa-overview. Accessed June 2023.
9National Eczema Association. Atopic Dermatitis. Available at: https://nationaleczema.org/eczema/types-of-eczema/atopic-dermatitis/. Accessed June 2023.